Wilson Leslie, Dohan Dan, Garibaldi Matthew, Szeto David, Timmerman Molly, Matheny Johnny
Department of Cllinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, CA, USA.
Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA, USA.
J Rehabil Assist Technol Eng. 2023 Jan 20;10:20556683231152418. doi: 10.1177/20556683231152418. eCollection 2023 Jan-Dec.
The patient's voice in shared decision-making has progressed from physician's office to regulatory decision-making for medical devices with FDA's Patient Preference Initiative. A discrete-choice preference measure for upper limb prosthetic devices was developed to investigate patient's risk/benefit preference choices for regulatory decision making.
Rapid ethnographic procedures were used to design a discrete-choice measure describing risk and benefits of osseointegration with myoelectric control and test in a pilot preference study in adults with upper limb loss. Primary outcome is utility of each choice based conjoint (CBC) attribute using mixed-effects regression. Utilities with and without video, and between genders were compared.
Strongest negative preference was for avoiding infection risk (B = -1.77, < 0.001) and chance of daily pain (B = -1.22, , 0.001). Strongest positive preference was for attaining complete independence when cooking dinner (B = 1.62, < 0.001) and smooth grip patterns at all levels (B = 1.62, B = 1.28, B = 1.26, < 0.001). Trade-offs showed a 1% increase in risk of serious/treatable infection resulted in a 1.77 decrease in relative preference. There were gender differences, and where video was used, preferences were stronger.
Strongest preferences were for attributes of functionality and independence versus connectedness and sensation but showed willingness to make risk-benefit trade-offs. Findings provide valuable information for regulatory benefit-risk decisions for prosthetic device innovations.
This study is not a clinical trial reporting results of a health care intervention so is not registered.
随着美国食品药品监督管理局(FDA)的患者偏好倡议,患者在共同决策中的声音已从医生办公室延伸至医疗器械的监管决策。为了研究患者在监管决策中对上肢假肢装置的风险/收益偏好选择,开发了一种离散选择偏好测量方法。
采用快速人种学程序设计一种离散选择测量方法,描述骨整合与肌电控制的风险和益处,并在一项针对上肢缺失成年人的偏好试点研究中进行测试。主要结果是使用混合效应回归分析每个基于选择的联合(CBC)属性的效用。比较有无视频情况下以及不同性别之间的效用。
最强烈的负面偏好是避免感染风险(B = -1.77,P < 0.001)和每日疼痛的可能性(B = -1.22,P < 0.001)。最强烈的正面偏好是在做晚餐时实现完全独立(B = 1.62,P < 0.001)以及在各个水平上实现平滑抓握模式(B = 1.62,B = 1.28,B = 1.26,P < 0.001)。权衡表明,严重/可治疗感染风险增加1%会导致相对偏好降低1.77。存在性别差异,并且在使用视频的情况下,偏好更强。
最强烈的偏好是功能和独立性属性而非连接性和感觉属性,但表明愿意进行风险-收益权衡。研究结果为假肢装置创新的监管利益-风险决策提供了有价值的信息。
本研究并非报告医疗保健干预结果的临床试验,因此未进行注册。